Akso Health Group (AHG)

$0.94

Live

Performance

  • $0.94
    $1.00
    $0.94
    downward going graph

    0.0%

    Downside

    Day's Volatility :6.0%

    Upside

    6.0%

    downward going graph
  • $0.53
    $2.90
    $0.94
    downward going graph

    43.62%

    Downside

    52 Weeks Volatility :81.72%

    Upside

    67.59%

    downward going graph

Returns

PeriodAkso Health GroupSector (Financials)Index (Russel 2000)
3 Months
-10.56%
11.1%
0.0%
6 Months
15.6%
17.9%
0.0%
1 Year
-16.5%
47.9%
0.0%
3 Years
-53.29%
18.9%
-23.0%

Highlights

Market Capitalization
223.9M
Book Value
$0.95
Earnings Per Share (EPS)
-0.21
Profit Margin
0.0%
Operating Margin TTM
-415.73%
Return On Assets TTM
-6.65%
Return On Equity TTM
-12.38%
Revenue TTM
2.4M
Revenue Per Share TTM
0.05
Quarterly Revenue Growth YOY
14.799999999999999%
Gross Profit TTM
1.3M
EBITDA
-14.2M
Diluted Eps TTM
-0.21
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Company Financials

FY19Y/Y Change
Revenue
61.3M
↓ 42.82%
Net Income
5.5M
↓ 91.55%
Net Profit Margin
9.02%
↓ 52.03%
FY20Y/Y Change
Revenue
11.4M
↓ 81.36%
Net Income
-71.2M
↓ 1386.89%
Net Profit Margin
-622.63%
↓ 631.65%
FY21Y/Y Change
Revenue
1.8M
↓ 84.65%
Net Income
-31.6M
↓ 55.68%
Net Profit Margin
-1.8K%
↓ 1175.29%
FY22Y/Y Change
Revenue
6.3M
↑ 259.62%
Net Income
-16.8M
↓ 46.6%
Net Profit Margin
-266.99%
↑ 1530.93%
FY23Y/Y Change
Revenue
13.2M
↑ 108.86%
Net Income
-13.1M
↓ 22.35%
Net Profit Margin
-99.26%
↑ 167.73%
FY24Y/Y Change
Revenue
2.4M
↓ 81.68%
Net Income
-9.5M
↓ 27.71%
Net Profit Margin
-391.78%
↓ 292.52%
Q2 FY22Q/Q Change
Revenue
5.9M
-
Net Income
815.4K
-
Net Profit Margin
13.75%
-
Q3 FY22Q/Q Change
Revenue
6.3T
↑ 1.0645237105E8%
Net Income
14.7M
↑ 1704.2%
Net Profit Margin
0.0%
↓ 13.75%
Q4 FY22Q/Q Change
Revenue
11.9M
↓ 100.0%
Net Income
810.3K
↓ 94.49%
Net Profit Margin
6.83%
↑ 6.83%
Q2 FY23Q/Q Change
Revenue
446.8K
↓ 96.24%
Net Income
-1.5M
↓ 289.07%
Net Profit Margin
-342.91%
↓ 349.74%
Q4 FY23Q/Q Change
Revenue
446.8K
↑ 0.0%
Net Income
-1.5M
↑ 0.0%
Net Profit Margin
-342.91%
↑ 0.0%
Q2 FY24Q/Q Change
Revenue
760.4K
↑ 70.19%
Net Income
-3.0M
↑ 95.85%
Net Profit Margin
-394.62%
↓ 51.71%
FY19Y/Y Change
Total Assets
173.3M
↑ 5.71%
Total Liabilities
46.8M
↑ 96.05%
FY20Y/Y Change
Total Assets
78.4M
↓ 54.76%
Total Liabilities
30.3M
↓ 35.23%
FY21Y/Y Change
Total Assets
31.7M
↓ 59.58%
Total Liabilities
14.4M
↓ 52.4%
FY22Y/Y Change
Total Assets
50.7M
↑ 59.95%
Total Liabilities
38.4M
↑ 166.37%
FY23Y/Y Change
Total Assets
20.5M
↓ 59.63%
Total Liabilities
11.6M
↓ 69.73%
FY24Y/Y Change
Total Assets
142.0M
↑ 594.12%
Total Liabilities
3.6M
↓ 69.07%
Q1 FY23Q/Q Change
Total Assets
20.5M
↓ 2.14%
Total Liabilities
11.6M
↑ 5.86%
Q2 FY23Q/Q Change
Total Assets
16.9M
↓ 17.5%
Total Liabilities
11.5M
↓ 0.62%
Q3 FY23Q/Q Change
Total Assets
16.9M
↑ 0.0%
Total Liabilities
11.5M
↑ 0.0%
Q4 FY23Q/Q Change
Total Assets
16.9M
↑ 0.0%
Total Liabilities
11.5M
↑ 0.0%
Q1 FY24Q/Q Change
Total Assets
142.0M
↑ 741.31%
Total Liabilities
3.6M
↓ 68.88%
Q2 FY24Q/Q Change
Total Assets
142.0M
↑ 0.0%
Total Liabilities
3.6M
↑ 0.0%
FY19Y/Y Change
Operating Cash Flow
-1.7M
↓ 101.97%
Investing Cash Flow
-68.1M
↑ 146.55%
Financing Cash Flow
-29.4K
↓ 100.06%
FY20Y/Y Change
Operating Cash Flow
-55.9M
↑ 3127.23%
Investing Cash Flow
12.8M
↓ 118.76%
Financing Cash Flow
-4.0M
↑ 13397.63%
FY21Y/Y Change
Operating Cash Flow
10.1M
↓ 118.0%
Investing Cash Flow
-662.0
↓ 100.01%
Financing Cash Flow
-9.0M
↑ 127.91%
FY22Y/Y Change
Operating Cash Flow
-8.6M
↓ 185.78%
Investing Cash Flow
-20.0M
↑ 3015588.82%
Financing Cash Flow
34.8M
↓ 484.87%
FY23Y/Y Change
Operating Cash Flow
-3.3M
↓ 62.29%
Investing Cash Flow
18.5M
↓ 192.52%
Financing Cash Flow
-27.5M
↓ 179.11%
Q2 FY22Q/Q Change
Operating Cash Flow
-667.1K
↓ 100.89%
Investing Cash Flow
10.0M
-
Financing Cash Flow
-13.8M
↓ 129.28%
Q3 FY22Q/Q Change
Operating Cash Flow
-667.1K
↑ 0.0%
Investing Cash Flow
10.0M
↑ 0.0%
Financing Cash Flow
-13.8M
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Akso Health Group is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Akso Health Group
Akso Health Group
-19.35%
15.6%
-16.5%
-53.29%
-53.29%
Cardinal Health, Inc.
Cardinal Health, Inc.
0.51%
9.32%
22.2%
129.13%
122.99%
Cencora Inc
Cencora Inc
3.99%
0.24%
25.74%
62.86%
96.16%
Mckesson Corporation
Mckesson Corporation
0.83%
-3.44%
13.16%
145.76%
245.57%
Henry Schein, Inc.
Henry Schein, Inc.
1.06%
0.49%
7.39%
-8.38%
15.09%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Akso Health Group
Akso Health Group
NA
NA
NA
0.0
-0.12
-0.07
NA
0.95
Cardinal Health, Inc.
Cardinal Health, Inc.
32.58
32.58
0.96
7.36
0.0
0.03
0.02
-13.17
Cencora Inc
Cencora Inc
25.59
25.59
1.33
13.63
1.88
0.03
0.01
4.7
Mckesson Corporation
Mckesson Corporation
22.73
22.73
1.48
27.59
0.0
0.04
0.01
-13.53
Henry Schein, Inc.
Henry Schein, Inc.
26.45
26.45
1.6
4.75
0.07
0.04
NA
27.64
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Akso Health Group
Akso Health Group
NA
$223.9M
-53.29%
NA
0.0%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$27.2B
122.99%
32.58
0.38%
Cencora Inc
Cencora Inc
Buy
$46.2B
96.16%
25.59
0.65%
Mckesson Corporation
Mckesson Corporation
Buy
$66.0B
245.57%
22.73
0.94%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.1B
15.09%
26.45
2.82%

Insights on Akso Health Group

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 446.79K → 760.37K (in $), with an average increase of 41.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, 14.71M → -3.00M (in $), with an average decrease of 119.9% per quarter

  • Vs COR

    In the last 1 year, Cencora Inc has given 25.8% return, outperforming this stock by 26.5%

Institutional Holdings

  • Renaissance Technologies Corp

    0.07%

  • UBS Group AG

    0.01%

  • Geode Capital Management, LLC

    0.01%

  • Rhumbline Advisers

    0.01%

  • Millennium Management LLC

    0.01%

Company Information

和信电子商务有限公司 is a company based out of china.

Organization
Akso Health Group
Employees
9
CEO
Ms. Yilin Wang
Industry
Services

Discover More

FAQs